Table 1.
Inclusion criteria concerning ALT and HBV DNA for all 319 patients.
Table 2.
Baseline Characteristics of all 319 patients.
Figure 1.
Distribution of liver necroinflammation (graded by Knodell histologic activity index) among 319 chronic hepatitis B patients.
Figure 2.
Distribution of liver fibrosis (staged by Ishak fibrosis score) in 319 chronic hepatitis B patients.
Figure 3.
Distribution of significant liver fibrosis (Ishak fibrosis score ≥3) among different age groups.
Figure 4.
Comparison of Ishak fibrosis scores among HBeAg-positive patients with normal ALT (p = 0.024).
Figure 5.
Comparison of Ishak fibrosis scores between ALT 1–2×ULN and ALT >2×ULN in both HBeAg-positive and HBeAg-negative patients.
Table 3.
Clinical parameters predictive of significant liver necroinflammation and fibrosis by multivariate analysis.